CHEUNG ANTHONY TZEYEW
SEC CIK 1998684 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | CTO | 102.9K | — | — | 2 | 2023-10-31 | 2024-03-18 |
Most active insiders at ENGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman William | Interim Chief Medical Off, Dir | $10.1K | — |
CHEUNG ANTHONY TZEYEW made no open-market trades at ENGN in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-20 | 2024-03-18 | ENGN | enGene Therapeutics Inc. | CHEUNG ANTHONY TZEYEW | CTO | M - OptEx | $0.89 | +52.9K | 102.9K | +106% | +$47.1K |
| D | 2023-11-02 | 2023-10-31 | ENGN | enGene Therapeutics Inc. | CHEUNG ANTHONY TZEYEW | CTO | A - Grant | — | +49.9K | 49.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations